METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS
- Application ID: EP12719993
- Status: █ The patent has been granted
This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). CSL Behring GmbH is specialized in A61. CSL Behring GmbH is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.